Top Medical Org Demands FDA Make COVID Treatment Hydroxychloroquine More Widely Available

Calvin Freiburger : Jul 31, 2020
LifeSiteNews.com

"The mortality rate from COVID-19 in countries that allow access to HCQ is only one-tenth the mortality rate in countries where there is interference with this medication, such as the United States." -AAPS general counsel Andrew Schlafly

[LifeSiteNews.com] The Association of American Physicians & Surgeons (AAPS) has submitted additional evidence to the US Department of Health & Human Services (HHS) and Food & Drug Administration (FDA) in hopes of compelling the agency to relax its restrictions on the use of hydroxychloroquine (HCQ) to treat COVID-19 among the general public. (Image: via News Channel 6 Now)

Last month, AAPS filed a motion for a preliminary injunction to compel HHS and CDC to release more of the tens of millions of doses in the government's possession to the public. The FDA has not officially cleared the drug for COVID-19 treatment (it has long been approved for malaria, autoimmune conditions, and arthritis), but has allowed it "to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible." (At the same time, the FDA warns not to use it outside of trials or hospitals.)

This week, AAPS followed up by submitting to the court additional evidence of the drug's safety and effectiveness.

"As confirmed by another recent study of thousands of patients at the Henry Ford Health System in Michigan, HCQ is both very safe and highly effective in treating COVID-19, reducing mortality by 50 percent," the group argued. "Countries with underdeveloped healthcare systems are using HCQ early and attaining far lower mortality than in the United States, where (HHS and the FDA) impede access to HCQ"... Subscribe for free to Breaking Christian News here

Continue reading here.